Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Cynata Therapeutics secures $8.1m funding after promising results from diabetic foot ulcers trial
Cynata Therapeutics Limited, a clinical-stage biotechnology company listed on the Australian Securities Exchange (ASX: CYP), has raised A$8.1 million through an institutional placement. The funding ... Read More
Lilly commits $3bn to Wisconsin facility to boost injectable medicine production
Eli Lilly and Company (Lilly) has unveiled plans for a $3 billion expansion of its newly acquired manufacturing facility in Kenosha County, Wisconsin, signalling a ... Read More
Laurus Bio secures Rs 160cr investment to accelerate expansion
Laurus Bio Private Limited, a subsidiary of Laurus Labs, has announced a significant equity investment totalling ₹160 crore. The investment comes from Eight Roads Ventures, ... Read More
Aurobindo Pharma’s subsidiary Eugia secures FDA nod for pazopanib tablets
Aurobindo Pharma Limited, through its wholly owned subsidiary Eugia Pharma Specialities Limited, has received final approval from the US Food and Drug Administration (USFDA) to ... Read More
Torrent Pharmaceuticals strengthens diabetes care portfolio with acquisition of anti-diabetes brands
Torrent Pharmaceuticals Limited, a leader in the global pharmaceutical industry, has furthered its diabetes care portfolio with a high-profile acquisition of anti-diabetes brands from Boehringer ... Read More
Trevi Therapeutics reports promising results for Oral Nalbuphine in human abuse potential study
Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, announced positive oral nalbuphine results from its human abuse potential (HAP) study evaluating the investigational therapy Haduvio™ for ... Read More
Innovent, Hutchmed announce conditional approval for cancer drug combination therapy
Innovent Biologics and Hutchmed (china) limited have received conditional nmpa approval for the combination therapy of tyvyt (sintilimab injection) and elunate (fruquintinib) for treating advanced ... Read More
Everest Medicines’ EVER001 shows promising Phase 1b/2a trial results for autoimmune kidney disease treatment
Everest Medicines has announced promising preliminary results from its ongoing Phase 1b/2a clinical trial of EVER001, a next-generation Bruton's tyrosine kinase (BTK) inhibitor, for the ... Read More
Janux Therapeutics advances prostate cancer treatment as stock soars
Janux Therapeutics made headlines with an extraordinary 54% surge in after-hours trading on Monday, bringing its stock price to $61.79. This sharp rise followed the ... Read More
Shanghai MicuRx advances MRX-4 trial results towards NDA approval
Shanghai MicuRx Pharmaceutical Co., Ltd. has announced a major breakthrough in antibacterial drug development, successfully completing its Phase III clinical trial of MRX-4 for injection ... Read More